Qiang Zheng
Chengdu, 610037, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Intra-Articular Delivery of a Low-Dose Adeno-Associated Virus-IL-1 Receptor Antagonist Vector Alleviates the Progress of Arthritis in an Osteoarthritis Rat Model.
Journal: Pharmaceutics
Published: October 08, 2024
An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species.
Journal: Nature communications
Published: September 20, 2023
Preclinical evaluation of KH631, a novel rAAV8 gene therapy product for neovascular age-related macular degeneration.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 21, 2023
Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis.
Journal: Human gene therapy
Published: June 29, 2021
Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics.
Journal: Molecular therapy. Methods & clinical development
Published: February 17, 2021
Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs.
Journal: Molecular therapy. Nucleic acids
Published: October 10, 2017
Efficient Transduction of Corneal Stroma by Adeno-Associated Viral Serotype Vectors for Implications in Gene Therapy of Corneal Diseases.
Journal: Human gene therapy
Published: March 23, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026